Curevac Stock Price

The CureVac 52-week high stock price is 15180 which is 1779 above the current share price. The latest closing stock price for CureVac as of September 30 2021 is 5462.

Curevac Cvac Announces Positive Data On Covid 19 Vaccine Nasdaq

According to the issued ratings of 5 analysts in the last year the consensus rating for CureVac stock is Hold based on the current 1 sell rating 1 hold rating and 3 buy ratings for CVAC.

Curevac stock price. View the latest CureVac NV. View CureVac stock share price financials funding rounds investors and more at Craft. CVAC forecast for the upcoming days Date Price Min Price Max Price.

This suggests a possible upside of 308 from the stocks current price. View real-time stock prices and stock quotes for a full financial overview. Use technical analysis tools such as candles Fibonacci to generate different instrument comparisons.

CureVac NV CVAC stock price charts trades the USs most popular discussion forums. Find the latest CUREVAC NV. Ordinary Shares CVAC Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets.

With analysts defining 3543-10607 as the low and high price targets we arrive at a consensus price target of 6554 for the trailing 12-month period. 102 rows Discover historical prices for CVAC stock on Yahoo Finance. The CureVac 52-week low stock price is 4612 which.

Get the latest CureVac BV CVAC real-time quote. Summary of all time highs changes and price drops for CureVac. Compare share trading platformsUse our comparison table to help you find a platform that fits you.

The all-time high CureVac stock closing price was 13627 on December 09 2020. View recent trades and share price information for CureVac NV EUR012. Their forecasts range from 4700 to 12300.

Historical daily share price chart and data for CureVac since 2021 adjusted for splits. The latest CureVac NV EUR012 share price. Stock analysis for CureVac NV CVACNASDAQ GM including stock price stock chart company news key statistics fundamentals and company profile.

A valuation method that multiplies the price of a companys stock by the total number of outstanding shares. 5CVDE stock quote history news and other vital information to help you with your stock trading and investing. CVAC Complete CureVac NV.

Confirm your payment details. - Try Now Risk-Free - Money-back guarantee. Open your brokerage account.

The average twelve-month price target for CureVac is 7333 with a high price target of 12300 and a low price target of 4700. CureVacs US shares are listed on the Nasdaq and plunged after hours from 9479 at Wednesdays close to 4954 at Thursdays market open. CVAC stock analyst estimates including earnings and revenue EPS upgrades and downgrades.

CureVac NV live price charts and stock performance over time. CureVac has raised 111 b in total funding. Free forex prices toplists indices and lots more.

How to buy shares in CureVac N-V. On average they anticipate CureVacs stock price to reach 7333 in the next twelve months. Stock price forecast for tomorrow and next weeks based on the last 30 days.

NASDAQCVACs beta value is currently sitting at 0 while the Average True Range indicator is currently displaying 309. Curevac NV stock price prediction is an act of determining the future value of Curevac NV shares using few different conventional methods such as EPS estimation analyst consensus or fundamental intrinsic valuationThe successful prediction of Curevac NVs future price could yield a significant profit. CureVac said early Tuesday it was halting development of its first messenger RNA-based Covid-19 vaccine and.

CureVac stock fell 145 in premarket trading. Complete an application with your details. CVAC stock price news historical charts analyst ratings and financial information from WSJ.

Stock news by MarketWatch. Get Our PREMIUM Forecast Now from ONLY 849. The 47 efficacy estimate is.

5 equities research analysts have issued 1 year price targets for CureVacs stock. CureVac valuation is 15 b and annual revenue was 1255 m in FY 2018.

4oby0gxuzpf5lm

Curevac Stock Soars After 213 3m Ipo Drug Delivery Business

Curevac Provides Update On Phase 2b 3 Trial Of First Generation Covid 19 Vaccine Candidate Cvncov Curevac

Stocks Near Record Highs On Recovery Hopes Curevac Sinks Reuters

N9qsevymtk6kim

Germany S Curevac Raises 213 Million In Ipo Boosted By Pandemic News Dw 14 08 2020

2

Tm2016252 23 424b4 None 46 55952s

Tm2016252 23 424b4 None 46 55952s

Covid 19 Vaccine Latest News Curevac Shot Shows Immune Response In Early Trial Bloomberg

Qzr80ijg6yfvkm

Curevac Says Second Covid 19 Vaccine Was Better In Preclinical Test Barron S

Stocks Near Record Highs On Recovery Hopes Curevac Sinks Reuters

Without A Coronavirus Vaccine Of Its Own Is There Any Hope For Curevac Stock The Motley Fool

Vir Biotechnology Avoid This Overvalued Stock In March 2020 Nasdaq Vir Seeking Alpha

Curevac Nv Share Price Eur0 12

Curevac Stock Wait For Concrete News Before Investing Nasdaq Cvac Seeking Alpha

Tm2016252 23 424b4 None 46 55952s

Gsk And Curevac S Second Covid Vaccine Yields Stronger Response Financial Times

Bagikan Artikel ini